Biocon reports strong 136 pct rise in net profit during Q3

India's biotech major Biocon on Thursday reported an Rs 217-crore consolidated net profit for the third quarter of fiscal 2018-19, registering a whopping 136 per cent annual growth from Rs 92 crore in the same period a year ago.

In a regulatory filing on the BSE, the city-based company said its consolidated revenue from operations for the quarter under review (Q3) grew 46 per cent year-on-year (YoY) to Rs 1,541-crore from Rs 1,058-crore in the like period a year ago. Sequentially, however, net profit declined 39 per cent from Rs 355 crore but revenue was up 17 per cent from Rs 1,321 crore a quarter ago.